Idebenone as a novel%25252C therapeutic approach for Duchenn…
Idebenone as a novel%25252C therapeutic approach for Duchenne muscular dystrophy%25253A results from a 12 month%25252C double-blind%25252C randomized placebo-controlled trial
Article, Chapter
Full text availability for this item
Coverage:
- 1991~present; volume:1~present;issue:1~present